TTY Biopharm Co Dividend Coverage

What does TTY Biopharm Co do? TTY Biopharm Co Ltd generates revenue through pharmaceutical and chemical drug production, primarily targeting domestic and overseas markets. The company's six business segments include Cancer Drug, Healthcare, Anti-Infective Drug, Domestic Cardiovascular and Gastrointestinal Drug, Mainland Medical Drug, and Other segments. Key products are oncology medicines such as anti-cancer and auxiliary drugs, anti-infective medicines like back-line antimicrobial agents and influenza vaccines, and healthcare medicines covering gastrointestinal, bone, metabolic health care, and infection treatment. Domestic and overseas customers purchase these products through the company's distribution channels. The Cancer Drug segment focuses on oncology medicines, including anti-cancer and auxiliary drugs, while the Anti-Infective Drug segment offers back-line antimicrobial agents and influenza vaccines. Healthcare segment products target gastrointestinal, bone, and metabolic health care, alongside infection treatment drugs. Mainland Medical Drug segment serves the mainland market with medical drugs, and Other segment handles additional product lines. All products are distributed domestically and internationally. Domestic and overseas markets drive sales of TTY Biopharm's pharmaceutical portfolio. Customers include healthcare providers and distributors purchasing oncology, anti-infective, and healthcare medicines. The Mainland Medical Drug segment specifically caters to the mainland market, while other segments serve broader regional demands. Product distribution spans both local and global channels. TTY Biopharm Co is one of the most popular companies on Eulerpool.